Medikaloka Hermina PT Cash Flow Conversion Efficiency
Medikaloka Hermina PT cash flow conversion efficiency. Based on the latest financial reports, Medikaloka Hermina PT (HEAL) has a cash flow conversion efficiency ratio of 0.032x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rp225.37 Billion ≈ $13.21 Million USD) by net assets (Rp7.01 Trillion ≈ $410.97 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Medikaloka Hermina PT (2015–2024)
Cash flow conversion efficiency of Medikaloka Hermina PT from 2015 to 2024. This chart illustrates how Medikaloka Hermina PT's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Medikaloka Hermina PT stock price for real-time trading data and today's change.
Medikaloka Hermina PT Cash Flow Conversion Ratio Explained
Medikaloka Hermina PT cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Medikaloka Hermina PT Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Medikaloka Hermina PT ranked by their cash flow conversion efficiency. Also see how much is Medikaloka Hermina PT worth for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
REalloys Inc.
NASDAQ:ALOY
|
-0.038x |
|
Noah Holdings Limited
F:6NO
|
0.050x |
|
iA Inc
KQ:038880
|
-0.005x |
|
Pulike Biological Engineering
SHG:603566
|
0.034x |
|
Pilani Investment and Industries Corporation Limited
NSE:PILANIINVS
|
-0.020x |
|
Suzhou Sonavox Electronics Co. Ltd. A
SHG:688533
|
0.090x |
|
GULF KEYSTONE PETR.
F:GVP1
|
N/A |
|
Nanjing Baose Co Ltd
SHE:300402
|
-0.058x |
Annual Cash Flow Conversion Efficiency for Medikaloka Hermina PT (2015–2024)
The table below shows the annual cash flow conversion efficiency of Medikaloka Hermina PT from 2015 to 2024. Review Medikaloka Hermina PT free cash flow efficiency to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | Rp5.87 Trillion ≈ $343.74 Million |
Rp1.14 Trillion ≈ $66.66 Million |
0.194x | -23.61% |
| 2023-12-31 | Rp5.20 Trillion ≈ $304.60 Million |
Rp1.32 Trillion ≈ $77.33 Million |
0.254x | +136.20% |
| 2022-12-31 | Rp4.69 Trillion ≈ $274.55 Million |
Rp503.58 Billion ≈ $29.51 Million |
0.107x | -74.60% |
| 2021-12-31 | Rp4.39 Trillion ≈ $257.02 Million |
Rp1.86 Trillion ≈ $108.77 Million |
0.423x | +27.07% |
| 2020-12-31 | Rp3.38 Trillion ≈ $198.18 Million |
Rp1.13 Trillion ≈ $66.01 Million |
0.333x | +60.80% |
| 2019-12-31 | Rp2.76 Trillion ≈ $161.98 Million |
Rp572.58 Billion ≈ $33.55 Million |
0.207x | +103.10% |
| 2018-12-31 | Rp2.37 Trillion ≈ $138.86 Million |
Rp241.67 Billion ≈ $14.16 Million |
0.102x | -79.03% |
| 2017-12-31 | Rp956.53 Billion ≈ $56.05 Million |
Rp465.08 Billion ≈ $27.25 Million |
0.486x | +68.84% |
| 2016-12-31 | Rp1.26 Trillion ≈ $73.83 Million |
Rp362.85 Billion ≈ $21.26 Million |
0.288x | +7.84% |
| 2015-12-31 | Rp957.59 Billion ≈ $56.11 Million |
Rp255.71 Billion ≈ $14.98 Million |
0.267x | -- |
About Medikaloka Hermina PT
PT Medikaloka Hermina Tbk, together with its subsidiaries, operates a network of hospitals in Indonesia. The company offers services in the areas of medical acupuncture, pediatrics, surgery, orthopedic surgery, plastic and reconstructive surgery, emergency medicine, forensic and medicolegal, dentistry, clinical nutrition, integrative medicine, cardiology, obstetrics and gynecology, nuclear medici… Read more